SG10201405420QA - Methods for producing yeast-based vaccines - Google Patents
Methods for producing yeast-based vaccinesInfo
- Publication number
- SG10201405420QA SG10201405420QA SG10201405420QA SG10201405420QA SG10201405420QA SG 10201405420Q A SG10201405420Q A SG 10201405420QA SG 10201405420Q A SG10201405420Q A SG 10201405420QA SG 10201405420Q A SG10201405420Q A SG 10201405420QA SG 10201405420Q A SG10201405420Q A SG 10201405420QA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- based vaccines
- producing yeast
- yeast
- producing
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89928107P | 2007-02-02 | 2007-02-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201405420QA true SG10201405420QA (en) | 2014-10-30 |
Family
ID=39682350
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201101501-3A SG171577A1 (en) | 2007-02-02 | 2008-02-01 | Methods for producing yeast-based vaccines |
| SG10201405420QA SG10201405420QA (en) | 2007-02-02 | 2008-02-01 | Methods for producing yeast-based vaccines |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201101501-3A SG171577A1 (en) | 2007-02-02 | 2008-02-01 | Methods for producing yeast-based vaccines |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9066893B2 (en) |
| EP (1) | EP2121013B1 (en) |
| JP (2) | JP5570819B2 (en) |
| KR (2) | KR101555641B1 (en) |
| CN (2) | CN104120086A (en) |
| AU (1) | AU2008214029B2 (en) |
| BR (1) | BRPI0807828B8 (en) |
| CA (1) | CA2676783C (en) |
| DK (1) | DK2121013T3 (en) |
| ES (1) | ES2527756T3 (en) |
| HK (1) | HK1136979A1 (en) |
| IL (2) | IL200176A (en) |
| MX (1) | MX2009008175A (en) |
| PL (1) | PL2121013T3 (en) |
| PT (1) | PT2121013E (en) |
| SG (2) | SG171577A1 (en) |
| SI (1) | SI2121013T1 (en) |
| WO (1) | WO2008097863A2 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003301021C1 (en) | 2002-12-16 | 2010-02-18 | Globelmmune, Inc. | Yeast-based vaccines as immunotherapy |
| CN101437964B (en) | 2004-10-18 | 2012-06-13 | 全球免疫股份有限公司 | Yeast-based therapy for chronic hepatitis c infection |
| AU2006268333B2 (en) * | 2005-07-11 | 2012-06-14 | Globeimmune, Inc. | Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| US20070172503A1 (en) | 2005-12-13 | 2007-07-26 | Mycologics,Inc. | Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines |
| TW200806789A (en) | 2006-03-27 | 2008-02-01 | Globeimmune Inc | RAS mutation and compositions and methods related thereto |
| AU2008214029B2 (en) * | 2007-02-02 | 2014-01-30 | Globelmmune, Inc. | Methods for producing yeast-based vaccines |
| BRPI0809247A2 (en) * | 2007-03-19 | 2014-09-09 | Globeimmune Inc | COMPOSITIONS AND METHODS FOR ABLATION OF THE MUTATIONAL ESCAPE OF CANCER-MARKED THERAPIES. |
| US8728489B2 (en) | 2008-09-19 | 2014-05-20 | Globeimmune, Inc. | Immunotherapy for chronic hepatitis C virus infection |
| JP5759980B2 (en) | 2009-04-17 | 2015-08-05 | グローブイミューン，インコーポレイテッド | Combination of immunotherapy compositions for cancer and infectious diseases |
| EP2477647B1 (en) | 2009-09-14 | 2016-01-13 | The Regents of the University of Colorado | Modulation of yeast-based immunotherapy products and responses |
| ES2696551T3 (en) | 2010-12-17 | 2019-01-16 | Globeimmune Inc | Compositions and methods for the treatment or prevention of human adenovirus-36 infection |
| EA028659B1 (en) | 2011-02-12 | 2017-12-29 | Глоубиммьюн, Инк. | Yeast-based therapeutic for treating chronic hepatitis b |
| EP2685995B1 (en) | 2011-03-17 | 2017-05-03 | Globeimmune, Inc. | Yeast-brachyury immunotherapeutic compositions |
| AU2012271625B2 (en) | 2011-06-14 | 2017-05-18 | Globeimmune, Inc. | Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection |
| WO2013025972A1 (en) | 2011-08-17 | 2013-02-21 | Globeimmune, Inc. | Yeast-muc1 immunotherapeutic compositions and uses thereof |
| EP2864792A1 (en) | 2012-06-26 | 2015-04-29 | Biodesix, Inc. | Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies |
| TWI674108B (en) | 2013-03-19 | 2019-10-11 | 美商環球免疫公司 | Yeast-based immunotherapy for chordoma |
| EP2978449B1 (en) | 2013-03-26 | 2021-09-08 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of human immunodeficiency virus infection |
| US10226522B2 (en) | 2013-08-30 | 2019-03-12 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of tuberculosis |
| CN106456677A (en) | 2014-04-11 | 2017-02-22 | 全球免疫股份有限公司 | Yeast-based immunotherapy and type i interferon sensitivity |
| EP3331552B1 (en) | 2015-08-03 | 2021-01-27 | Globeimmune, Inc. | Modified yeast-brachyury immunotherapeutic compositions |
| US20210154250A1 (en) * | 2018-05-15 | 2021-05-27 | Globeimmune, Inc. | Lysates of recombinant yeast for inducing cellular immune responses |
| CN112334572A (en) | 2018-06-19 | 2021-02-05 | 南特细胞公司 | HIV treatment compositions and methods |
| WO2020061203A1 (en) | 2018-09-21 | 2020-03-26 | Nantcell, Inc. | Methods and compositions for modulating myeloid-derived suppressor cells |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2486400B1 (en) | 1980-07-09 | 1986-05-30 | Univablot | MEDICINAL PRODUCTS BASED ON YEAST OR THEIR INSOLUBLE EXTRACTS |
| NZ199722A (en) | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
| US4775622A (en) | 1982-03-08 | 1988-10-04 | Genentech, Inc. | Expression, processing and secretion of heterologous protein by yeast |
| US5310654A (en) | 1985-07-31 | 1994-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Method for determining virulence of Yersinia |
| US5234830A (en) | 1988-02-03 | 1993-08-10 | Suntory Limited | DNA encoding a KEX2 endoprotease without a C-terminal hydrophobic region |
| IL95019A0 (en) | 1989-08-09 | 1991-06-10 | Mycogen Corp | Process for encapsulation of biologicals |
| JP3510639B2 (en) | 1991-06-28 | 2004-03-29 | カルピス株式会社 | Functional food or health food with a function to regulate interleukin production |
| JP3091851B2 (en) | 1992-11-06 | 2000-09-25 | 工業技術院長 | Production method of mammalian high mannose glycoprotein sugar chain by yeast |
| US5413914A (en) | 1993-07-07 | 1995-05-09 | The Regents Of The University Of Colorado | Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| US5830463A (en) | 1993-07-07 | 1998-11-03 | University Technology Corporation | Yeast-based delivery vehicles |
| US5858378A (en) | 1996-05-02 | 1999-01-12 | Galagen, Inc. | Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen |
| WO1998035049A1 (en) | 1997-02-07 | 1998-08-13 | Oriental Yeast Co., Ltd. | Recombinant yeast pdi and process for preparing the same |
| GB9902000D0 (en) | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
| DK1272213T3 (en) | 2000-04-06 | 2006-07-10 | Seer Pharmaceuticals Llc | Microbial delivery system |
| AU2002225681A1 (en) | 2000-11-15 | 2002-05-27 | Globe Immune, Inc. | Yeast-dentritic cell vaccines and uses thereof |
| JP4288862B2 (en) | 2001-03-30 | 2009-07-01 | トヨタ自動車株式会社 | Method for producing prenyl alcohol |
| AU2003301021C1 (en) | 2002-12-16 | 2010-02-18 | Globelmmune, Inc. | Yeast-based vaccines as immunotherapy |
| US8343502B2 (en) | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
| US7439042B2 (en) | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
| KR100507665B1 (en) | 2003-03-25 | 2005-08-10 | 김경숙 | Vector for Expression of Ferritin Hetropolymer within Yeast and Recombinant Yeast Transformed with The Expression Vector |
| CN101437964B (en) | 2004-10-18 | 2012-06-13 | 全球免疫股份有限公司 | Yeast-based therapy for chronic hepatitis c infection |
| JP4904086B2 (en) | 2005-05-25 | 2012-03-28 | 公益財団法人微生物化学研究会 | Jellyfish decomposition waste liquid treatment apparatus and treatment method, and microorganism |
| AU2006268333B2 (en) | 2005-07-11 | 2012-06-14 | Globeimmune, Inc. | Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| US20070172503A1 (en) | 2005-12-13 | 2007-07-26 | Mycologics,Inc. | Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines |
| EP1988919A4 (en) * | 2006-02-02 | 2009-06-10 | Globeimmune Inc | Yeast-based vaccine for inducing an immune response |
| TW200806789A (en) | 2006-03-27 | 2008-02-01 | Globeimmune Inc | RAS mutation and compositions and methods related thereto |
| AU2008214029B2 (en) | 2007-02-02 | 2014-01-30 | Globelmmune, Inc. | Methods for producing yeast-based vaccines |
| BRPI0809247A2 (en) | 2007-03-19 | 2014-09-09 | Globeimmune Inc | COMPOSITIONS AND METHODS FOR ABLATION OF THE MUTATIONAL ESCAPE OF CANCER-MARKED THERAPIES. |
| US8728489B2 (en) | 2008-09-19 | 2014-05-20 | Globeimmune, Inc. | Immunotherapy for chronic hepatitis C virus infection |
| WO2010065626A1 (en) | 2008-12-02 | 2010-06-10 | Globeimmune, Inc. | Genotyping tools, methods and kits |
| JP5759980B2 (en) | 2009-04-17 | 2015-08-05 | グローブイミューン，インコーポレイテッド | Combination of immunotherapy compositions for cancer and infectious diseases |
| EP2477647B1 (en) | 2009-09-14 | 2016-01-13 | The Regents of the University of Colorado | Modulation of yeast-based immunotherapy products and responses |
| JP2013522302A (en) | 2010-03-14 | 2013-06-13 | グローブイミューン，インコーポレイテッド | Pharmacogenomics and therapeutic response guide treatment of infectious diseases using yeast-based immunotherapy |
-
2008
- 2008-02-01 AU AU2008214029A patent/AU2008214029B2/en active Active
- 2008-02-01 CN CN201410244501.4A patent/CN104120086A/en not_active Withdrawn
- 2008-02-01 DK DK08714176.8T patent/DK2121013T3/en active
- 2008-02-01 WO PCT/US2008/052843 patent/WO2008097863A2/en active Application Filing
- 2008-02-01 CN CN200880010797.6A patent/CN101687030B/en active Active
- 2008-02-01 MX MX2009008175A patent/MX2009008175A/en active IP Right Grant
- 2008-02-01 CA CA2676783A patent/CA2676783C/en active Active
- 2008-02-01 KR KR1020097017916A patent/KR101555641B1/en active IP Right Grant
- 2008-02-01 BR BRPI0807828A patent/BRPI0807828B8/en active IP Right Grant
- 2008-02-01 SG SG201101501-3A patent/SG171577A1/en unknown
- 2008-02-01 PL PL08714176T patent/PL2121013T3/en unknown
- 2008-02-01 US US12/525,045 patent/US9066893B2/en active Active
- 2008-02-01 KR KR1020147033308A patent/KR20150006022A/en not_active Application Discontinuation
- 2008-02-01 JP JP2009548478A patent/JP5570819B2/en active Active
- 2008-02-01 PT PT87141768T patent/PT2121013E/en unknown
- 2008-02-01 EP EP08714176.8A patent/EP2121013B1/en active Active
- 2008-02-01 SG SG10201405420QA patent/SG10201405420QA/en unknown
- 2008-02-01 ES ES08714176.8T patent/ES2527756T3/en active Active
- 2008-02-01 SI SI200831360T patent/SI2121013T1/en unknown
-
2009
- 2009-07-30 IL IL200176A patent/IL200176A/en active IP Right Grant
-
2010
- 2010-05-24 HK HK10105007.8A patent/HK1136979A1/en unknown
-
2013
- 2013-03-13 US US13/798,725 patent/US9549970B2/en active Active
-
2014
- 2014-06-25 JP JP2014129979A patent/JP2014223072A/en not_active Withdrawn
-
2015
- 2015-02-25 IL IL237406A patent/IL237406A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL237406A0 (en) | Improved methods for producing yeast-based vaccines | |
| HK1143328A1 (en) | Method for producing viral vaccines | |
| GB0700136D0 (en) | Process for manufacturing vaccines | |
| IL211233A0 (en) | Vaccine | |
| IL208660A0 (en) | Coccididosis vaccines | |
| HRP20151124T1 (en) | Vaccine | |
| ZA201001029B (en) | Vaccines | |
| GB0822001D0 (en) | Vaccine | |
| HRP20150775T1 (en) | Method for preparing hypoallergens | |
| EP2068904A4 (en) | Methods for preparing diazonamides | |
| EP2221306A4 (en) | Method for producing 2-azaadamantane | |
| GB0810710D0 (en) | Vaccine | |
| IL208652A0 (en) | Vaccine | |
| GB0816284D0 (en) | Vaccine | |
| GB0816447D0 (en) | Vaccine | |
| ZA200907695B (en) | Process for preparing dorzolam ide | |
| GB2455650B (en) | Vaccines for brucellosis | |
| GB0801326D0 (en) | Vaccines | |
| EP2154125A4 (en) | Method for producing arylhydroxylamine | |
| ZA201001017B (en) | Method for producing n-methacryloyl-4-cyano-3-trifluoromethylaniline | |
| GB0818459D0 (en) | Vaccines | |
| GB0706388D0 (en) | Vaccine production | |
| GB0804285D0 (en) | Vaccine production | |
| GB0810215D0 (en) | Vaccine | |
| GB0809781D0 (en) | Vaccine |